Katherine D. Crew

8.9k total citations · 1 hit paper
181 papers, 6.0k citations indexed

About

Katherine D. Crew is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Katherine D. Crew has authored 181 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Oncology, 62 papers in Genetics and 37 papers in Cancer Research. Recurrent topics in Katherine D. Crew's work include BRCA gene mutations in cancer (37 papers), Cancer Treatment and Pharmacology (30 papers) and Global Cancer Incidence and Screening (29 papers). Katherine D. Crew is often cited by papers focused on BRCA gene mutations in cancer (37 papers), Cancer Treatment and Pharmacology (30 papers) and Global Cancer Incidence and Screening (29 papers). Katherine D. Crew collaborates with scholars based in United States, South Africa and United Kingdom. Katherine D. Crew's co-authors include Alfred I. Neugut, Dawn L. Hershman, Heather Greenlee, Lois Brafman, Jillian L. Capodice, Déborah Fuentes, Danielle Awad, George Raptis, Serge Cremers and Elizabeth Shane and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Katherine D. Crew

171 papers receiving 5.8k citations

Hit Papers

Epidemiology of gastric cancer 2006 2026 2012 2019 2006 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Epidemiology of gastric cancer
    2006 1.6k citations Katherine D. Crew et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine D. Crew United States 36 2.8k 1.3k 1.1k 1.1k 1.0k 181 6.0k
Jeffrey J. Kirshner United States 35 2.2k 0.8× 939 0.7× 399 0.4× 1.0k 1.0× 330 0.3× 89 5.0k
Paul J. Limburg United States 48 3.8k 1.3× 1.4k 1.1× 1.6k 1.4× 1.4k 1.3× 777 0.7× 266 7.3k
Seok Jin Nam South Korea 47 3.5k 1.2× 1.3k 1.0× 1.9k 1.7× 1.4k 1.3× 711 0.7× 427 8.9k
James A. Mailliard United States 38 3.8k 1.4× 1.8k 1.3× 772 0.7× 825 0.8× 775 0.7× 92 6.8k
Søren Friis Denmark 44 1.6k 0.6× 1.2k 0.9× 1.1k 0.9× 1.9k 1.7× 633 0.6× 204 6.6k
Kathy B. Baumgartner United States 48 4.7k 1.7× 1.6k 1.2× 1.5k 1.3× 428 0.4× 806 0.8× 167 8.3k
M C Yu United States 47 1.6k 0.6× 889 0.7× 1.9k 1.7× 718 0.7× 957 0.9× 77 6.6k
Tom R. Fitch United States 34 2.0k 0.7× 1.3k 1.0× 1.2k 1.0× 763 0.7× 251 0.2× 97 4.6k
Leif Bergkvist Sweden 51 3.0k 1.1× 578 0.4× 715 0.6× 1.5k 1.3× 1.8k 1.7× 156 7.9k
Koji Oba Japan 37 1.6k 0.6× 1.5k 1.1× 930 0.8× 1.4k 1.3× 257 0.2× 273 5.7k

Countries citing papers authored by Katherine D. Crew

Since Specialization
Citations

This map shows the geographic impact of Katherine D. Crew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine D. Crew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine D. Crew more than expected).

Fields of papers citing papers by Katherine D. Crew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine D. Crew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine D. Crew. The network helps show where Katherine D. Crew may publish in the future.

Co-authorship network of co-authors of Katherine D. Crew

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine D. Crew. A scholar is included among the top collaborators of Katherine D. Crew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine D. Crew. Katherine D. Crew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Shikun, Joshua R. Cook, Neil Vasan, et al.. (2025). Continuous glucose monitoring to characterize hyperglycemia during chemotherapy for early stage breast cancer. Breast Cancer Research and Treatment. 212(3). 511–519. 3 indexed citations
3.
4.
Wang, Ying, J. Raikhelkar, Neil Vasan, et al.. (2024). Abstract PO1-10-04: Racial and Ethnic Disparities in Anthracycline and HER2-targeted Cardiotoxicity in Patients With Breast Cancer Using Global Longitudinal Strain Imaging Techniques. Cancer Research. 84(9_Supplement). PO1–10. 1 indexed citations
5.
Campbell, Peter M., Melissa Beauchemin, Elena B. Elkin, et al.. (2024). Pharmacist-Led Video Consultation to Identify and Mitigate Drug Interactions Among Patients Initiating Oral Anticancer Drugs. JCO Oncology Practice. 21(4). 544–551.
6.
O’Neil, Daniel S., Yehoda M. Martei, Katherine D. Crew, et al.. (2023). Time to Cancer Treatment and Chemotherapy Relative Dose Intensity for Patients With Breast Cancer Living With HIV. JAMA Network Open. 6(12). e2346223–e2346223. 1 indexed citations
7.
Lederman, Ruth, Naomi Y. Ko, Daniel A. Gundersen, et al.. (2023). Breast cancer treatment receipt and the role of financial stress, health literacy, and numeracy among diverse breast cancer survivors. Breast Cancer Research and Treatment. 200(1). 127–137. 7 indexed citations
8.
Freedman, Rachel A., Naomi Y. Ko, Ruth Lederman, et al.. (2022). Breast cancer knowledge and understanding treatment rationales among diverse breast cancer survivors. Breast Cancer Research and Treatment. 196(3). 623–633. 8 indexed citations
9.
Trivedi, Meghna S., Nadir Arber, Eitan Friedman, et al.. (2022). Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy. Cancer Prevention Research. 15(11). 721–726. 3 indexed citations
10.
Henry, N. Lynn, Joseph M. Unger, Cathee Till, et al.. (2021). Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms. JNCI Cancer Spectrum. 5(6). 2 indexed citations
11.
Wright, Jason D., Grace Clarke Hillyer, Meghna S. Trivedi, et al.. (2021). Care Delivery Impact of the COVID-19 Pandemic on Breast Cancer Care. JCO Oncology Practice. 17(8). e1215–e1224. 39 indexed citations
12.
Hershman, Dawn L., Melissa Accordino, Sherry Shen, et al.. (2020). Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac events. Cancer. 126(7). 1541–1549. 13 indexed citations
13.
Crew, Katherine D., Garnet L. Anderson, Dawn L. Hershman, et al.. (2019). Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812). Cancer Prevention Research. 12(7). 481–490. 16 indexed citations
14.
Trivedi, Meghna S., et al.. (2018). Factors Associated with False Positive Results on Screening Mammography in a Population of Predominantly Hispanic Women. Cancer Epidemiology Biomarkers & Prevention. 27(4). 446–453. 17 indexed citations
15.
Shen, Sherry, Joseph M. Unger, Katherine D. Crew, et al.. (2018). Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927). Breast Cancer Research and Treatment. 172(3). 603–610. 33 indexed citations
16.
Lim, Emerson A., Jacqueline Gunther, Hyun Koo Kim, et al.. (2017). Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Research and Treatment. 162(3). 533–540. 13 indexed citations
17.
Greenlee, Heather, Isobel R. Contento, Wahida Karmally, et al.. (2015). ¡Cocinar Para Su Salud!: Randomized Controlled Trial of a Culturally Based Dietary Intervention among Hispanic Breast Cancer Survivors. Journal of the Academy of Nutrition and Dietetics. 115(5). 709–723.e3. 58 indexed citations
18.
Greenlee, Heather, Isobel R. Contento, Wahida Karmally, et al.. (2015). ¡Cocinar Para Su Salud!: Randomized Controlled Trial of a Culturally Based Dietary Intervention among Hispanic Breast Cancer Survivors. Journal of the Academy of Nutrition and Dietetics. 115(5). S42–S56.e3. 20 indexed citations
19.
Hershman, Dawn L., Joseph M. Unger, Katherine D. Crew, et al.. (2013). Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy. Journal of Clinical Oncology. 31(20). 2627–2633. 145 indexed citations
20.
Crew, Katherine D., Powel H. Brown, Heather Greenlee, et al.. (2012). Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer. Cancer Prevention Research. 5(9). 1144–1154. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey J. Kirshner Breakdown of academic impact, for papers by Paul J. Limburg Breakdown of academic impact, for papers by Seok Jin Nam Breakdown of academic impact, for papers by James A. Mailliard Breakdown of academic impact, for papers by Søren Friis Breakdown of academic impact, for papers by Kathy B. Baumgartner Breakdown of academic impact, for papers by M C Yu Breakdown of academic impact, for papers by Tom R. Fitch Breakdown of academic impact, for papers by Leif Bergkvist Breakdown of academic impact, for papers by Koji Oba
Rankless by CCL
2026